DNA methylation at enhancers identifies distinct breast cancer lineages

Hepatocyte Nuclear Factor 3-alpha 0301 basic medicine 570 [SDV]Life Sciences [q-bio] Science Quantitative Trait Loci 610 [SDV.CAN]Life Sciences [q-bio]/Cancer Breast Neoplasms GATA3 Transcription Factor Article Epigenesis, Genetic 03 medical and health sciences Humans Binding Sites Q Estrogen Receptor alpha Reproducibility of Results DNA Methylation 3. Good health Gene Expression Regulation, Neoplastic Enhancer Elements, Genetic MCF-7 Cells CpG Islands Female Transcription Factors
DOI: 10.1038/s41467-017-00510-x Publication Date: 2017-11-03T14:40:21Z
ABSTRACT
AbstractBreast cancers exhibit genome-wide aberrant DNA methylation patterns. To investigate how these affect the transcriptome and which changes are linked to transformation or progression, we apply genome-wide expression–methylation quantitative trait loci (emQTL) analysis between DNA methylation and gene expression. On a whole genome scale, in cis and in trans, DNA methylation and gene expression have remarkably and reproducibly conserved patterns of association in three breast cancer cohorts (n = 104, n = 253 and n = 277). The expression–methylation quantitative trait loci associations form two main clusters; one relates to tumor infiltrating immune cell signatures and the other to estrogen receptor signaling. In the estrogen related cluster, using ChromHMM segmentation and transcription factor chromatin immunoprecipitation sequencing data, we identify transcriptional networks regulated in a cell lineage-specific manner by DNA methylation at enhancers. These networks are strongly dominated by ERα, FOXA1 or GATA3 and their targets were functionally validated using knockdown by small interfering RNA or GRO-seq analysis after transcriptional stimulation with estrogen.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (62)
CITATIONS (108)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....